DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

LillyDirect (Zepbound) vs NexLife: November 2026 prices compared

As of November 20, 2026, from each program’s own page: on compounded tirzepatide, only NexLife prints a comparable month-to-month price, $129 a month; LillyDirect (Zepbound) is a brand route with no compounded tirzepatide price, so no like-for-like comparison is possible.

Released · Last reviewed · how we verify

On compounded semaglutide, only NexLife prints a comparable month-to-month price, $109 a month; LillyDirect (Zepbound) is a brand route with no compounded semaglutide price, so no like-for-like comparison is possible.

LillyDirect (Zepbound) and NexLife, measure by measure

LillyDirect (Zepbound) and NexLife side by side, from each program’s own page read November 20, 2026 (all-in: medication plus any required recurring fee, before tax)
MeasureLillyDirect (Zepbound)NexLife
Tirzepatide, month to month—$129 (per month)
Tirzepatide, lowest printed—$115 (12-month plan)
Semaglutide, month to month—$109 (per month)
Semaglutide, lowest printed—$95 (12-month plan)
Dose pricingpriced by dose or not statedsame price at every dose
Membership or program feenonenone
Computed scorenot scored (brand route)33.6 of 40 (position 4 of 27)
FDA warning lettersnone listed730096 (2026-06-08)
November 20 readfirst-party readfirst-party read

Strengths and limitations: which fits whom

LillyDirect (Zepbound) suits someone who wants brand medication, FDA-approved, and accepts a higher monthly cost or has coverage. NexLife prints one price at every dose with no membership, so a dose increase does not change the bill. Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy; a licensed clinician decides whether either is appropriate for you.

Regulatory record

FDA’s warning-letter index lists warning letter 730096 (dated June 8, 2026, subject “False & Misleading Claims/Misbranded (Telehealth)”) to NexLife; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding.

Check LillyDirect (Zepbound)’s current prices ↗

Frequently asked

Which is cheaper, LillyDirect (Zepbound) or NexLife?

On compounded tirzepatide, only NexLife prints a comparable month-to-month price, $129 a month; LillyDirect (Zepbound) is a brand route with no compounded tirzepatide price, so no like-for-like comparison is possible. On compounded semaglutide, only NexLife prints a comparable month-to-month price, $109 a month; LillyDirect (Zepbound) is a brand route with no compounded semaglutide price, so no like-for-like comparison is possible.

Do LillyDirect (Zepbound) and NexLife charge a membership fee?

LillyDirect (Zepbound): no membership fee; NexLife: no membership fee. This site folds any required recurring fee into the all-in figures above, so the comparison already counts it.

Are LillyDirect (Zepbound) and NexLife medications FDA-approved?

Compounded tirzepatide and semaglutide from any telehealth program are not FDA-approved and are not the same products as Zepbound, Mounjaro, Wegovy or Ozempic. Brand medications sold through a manufacturer or a brand route are FDA-approved. Ask each program which pharmacy fills the prescription.

LillyDirect (Zepbound) recordNexLife recordNexLife alternativesAll head-to-headsRankingsPrice database

Sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.